IRIS
TORRE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.918
NA - Nord America 440
AS - Asia 434
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 21
AF - Africa 8
OC - Oceania 2
Totale 5.869
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 4.857
US - Stati Uniti d'America 401
SG - Singapore 198
CN - Cina 107
VN - Vietnam 64
FR - Francia 37
BR - Brasile 28
BD - Bangladesh 25
CA - Canada 15
HK - Hong Kong 14
AR - Argentina 7
GB - Regno Unito 6
MX - Messico 6
HN - Honduras 5
JM - Giamaica 5
NL - Olanda 5
EC - Ecuador 4
FI - Finlandia 4
DE - Germania 3
IN - India 3
IQ - Iraq 3
KR - Corea 3
SV - El Salvador 3
AU - Australia 2
CO - Colombia 2
CR - Costa Rica 2
JO - Giordania 2
JP - Giappone 2
KE - Kenya 2
MA - Marocco 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
TR - Turchia 2
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ES - Italia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
IE - Irlanda 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
QA - Qatar 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.848
Salva come PNG Salva come JPEG
Città #
Genova 3.013
Genoa 1.082
Rapallo 438
Vado Ligure 270
San Jose 119
Singapore 84
Ashburn 45
Lauterbourg 33
New York 24
Santa Clara 18
Ho Chi Minh City 17
Beijing 15
Hong Kong 14
Hanoi 11
Los Angeles 7
Phoenix 6
Amsterdam 5
Bordighera 5
Buffalo 5
Detroit 5
Rome 5
Chicago 4
Helsinki 4
Mexico City 4
Milan 4
Montreal 4
Tianjin 4
Da Nang 3
Dallas 3
Philadelphia 3
San Salvador 3
Tegucigalpa 3
Toronto 3
Alpharetta 2
Brescia 2
Brooklyn 2
Bình Dương 2
Bắc Ninh 2
Cagayan de Oro 2
Carmichael 2
City of London 2
DeLand 2
Dearborn 2
Des Moines 2
East Hartford 2
Helotes 2
Janesville 2
Kingston 2
London 2
Lyman 2
Marietta 2
Mumbai 2
Nairobi 2
Omaha 2
Orem 2
Paris 2
Quảng Ngãi 2
Roseville 2
San Francisco 2
San José 2
São Paulo 2
Troy 2
Turin 2
Winchester 2
'Ewa Beach 1
Addis Ababa 1
Al Kazimiyah 1
Al Maḩallah al Kubrá 1
Amman 1
Andover 1
Antakya 1
Asunción 1
Athens 1
Atlanta 1
Baku 1
Bangkok 1
Barbacena 1
Bengaluru 1
Biên Hòa 1
Bloomfield 1
Bogotá 1
Bologna 1
Boynton Beach 1
Bragado 1
Brasília 1
Bristol 1
Bucheon-si 1
Bình Phước 1
Bắc Giang 1
Cabo Frio 1
Cachoeirinha 1
Cagliari 1
Camilla 1
Campinas 1
Candelo 1
Cantanhede 1
Cardiff 1
Carlsbad 1
Casablanca 1
Casteldaccia 1
Totale 5.361
Salva come PNG Salva come JPEG
Nome #
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 231
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 230
Hepatitis G virus infection in haemodialysis and in peritoneal dialysis patients. 228
Circadian secretion of melatonin and thyrotropin in hospitalized aged patients. 179
Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity. 178
Peripheral blood serum markers for apoptosis and liver fibrosis: Are they trustworthy indicators of liver realness? 176
Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals 170
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy. 169
Soluble apoptosis molecules in primary biliary cirrhosis: analysis and commitment of the Fas and tumour necrosis factor-related apoptosis-inducing ligand systems in comparison with chronic hepatitis C. 164
Interferon retreatment in chronic hepatitis C: wich patients to choose, and what schedule to use 162
Antiviral activity of amantadine in elderly patients with chronic hepatitis C 160
Clinical implications of mutations in the hepatitis B virus genome. 159
Clearance kinetics of hepatitis C virus under different antiviral therapies. 156
Clinical and virological survey of patients with hepatitis B surface antigen in an Italian region: clinical considerations and disease burden 153
Effects of pyridostigmine, corticotropin-releasing hormone and growth hormone-releasing hormone on the pituitary-adrenal axis and on growth hormone secretion in dementia. 151
A significant proportion of patients with chronic hepatitis B who are candidates for antiviral treatment are untreated: a region-wide survey in Italy 150
Continuous lamivudine treatment in an OLT patient despite the appearance of HBV resistant strain: longitudinal analysis. 149
Evolution of wild-type and precore mutant HBV infection after liver transplantation. 145
Monotherapy with Pegylated Interferon Alpha-2a in Hemodialyzed Patients with Chronic Hepatitis C 144
Pegylated interferon and ribavirin in re-treatment of responder-relapser HCV patients. 143
Course of oesophageal varices and performance of non-invasive predictors following Hepatitis C Virus clearance in compensated advanced chronic liver disease 143
Regression of Fibrosis After DAAs Treatment of Patients with HCV Cirrhosis: Transposability to Non-Decompensated Patients 139
Elevations in ALT levels late the course of antiviral therapy in HCV-RNA negative patients are associated with virological relapse 136
Prospective evaluation of primary infection due to HCV, HGV or TTV in children with newly diagnosed neoplasia. 134
Kinetics of soluble tumour necrosis factor (TNF)-alpha receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-alpha alone, IFN-alpha plus amantadine or plus ribavirin. 134
Tumor necrosis factor receptors in patients with chronic hepatitis B virus infection. 133
TT virus infection in haemodialysis patients 133
Erythrocytes cell wall defects correlate with the stage of liver cirrhosis 133
Chronic hepatitis C. New therapeutic strategies. 132
Soluble tumor necrosis factor-related ligand (sTRAIL) levels and kinetics during antiviral treatment in chronic hepatitis C 129
Amantadine: a different approach. 128
Hepatitis B virus variants with core gene deletions in the evolution of chronic hepatitis B infection. 125
Serum lamivudine levels in the presence of a lamivudine-resistant HBV mutant 124
Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients. 122
Interferon beta-1a alone or in combination with ribavirin: a randomized trial to compare efficacy and safety in chronic hepatitis C. 121
Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus. 111
Initial high dose of lamivudine delays the appearance of viral resistance in chronic hepatitis B patients 106
Evaluation of a new hepatitis C virus sequecing assay as a routine method for genotyping 105
Sex hormones, gonadotropins and prolactin in male epileptic subjects in remission: role of the epileptic syndrome and of antiepileptic drugs. 101
Soluble beta2-mu-associated and beta2-mu-free HLA class I heavy chain serum levels in interferon-alpha nonresponder chronic hepatitis C patients. Markers of immune activation, and response to antiviral retreatment. 83
Totale 5.869
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.528
article - articoli 17.528
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.056
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022414 0 0 27 46 17 42 31 112 21 56 14 48
2022/2023536 59 58 7 45 81 90 3 48 86 5 48 6
2023/2024224 7 37 3 31 22 34 5 8 13 1 28 35
2024/2025729 30 43 11 54 96 57 59 150 17 26 80 106
2025/20261.151 177 30 44 76 177 83 166 56 95 101 71 75
2026/2027197 99 28 70 0 0 0 0 0 0 0 0 0
Totale 5.869